Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: A tale of two antigens implicated in Graves' disease

Journal of Immunology

Volumn 181, Issue 6, 2008, Pages 4397-4405

  Tsui, Shanli ^a   Naik, Vibha ^a   Hoa, Neil ^d   Hwang, Catherine J ^a,b   Afifiyan, Nikoo F ^a   Hikim, Amiya Sinha ^a   Gianoukakis, Andrew G ^a,c   Douglas, Raymond S ^a,b,c   Smith, Terry J ^a,b,c,d  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b JULES STEIN EYE INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; SOMATOMEDIN C RECEPTOR; THYROTROPIN; AUTOANTIGEN; SOMATOMEDIN C; THYROTROPIN RECEPTOR;

ARTICLE; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; ENDOCRINE OPHTHALMOPATHY; ENZYME PHOSPHORYLATION; FIBROBLAST; GRAVES DISEASE; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; ORBIT; PRIORITY JOURNAL; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; THYROID GLAND;

AUTOANTIGENS; CELL PROLIFERATION; CELLS, CULTURED; FIBROBLASTS; GRAVES DISEASE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; ORBIT; RECEPTOR, IGF TYPE 1; RECEPTORS, THYROTROPIN; THYROID GLAND;

EID: 56149127454     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.6.4397     Document Type: Article

References (70)

1. Adams, T. E., V. C. Epa, T. P. J. Garrett, and C. W. Ward. 2000. Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol. Life Sci. 57: 1050-1093. (Pubitemid 30598754)
2. De Meyts, P., and J. Whittaker. 2002. Structural biology of insulin and IGF1 receptors: implications for drug design. Nat. Rev. Drug Discov. 1: 769-783. (Pubitemid 37361561)
3. Dupont, J., A. M. Fernandez, C. A. Glackin, L. Helman, and D. LeRoith. 2001. Insulin-like growth factor 1 (IGF-1)-induced twist expression is involved in the anti-apoptotic effects of the IGF-1 receptor. J. Biol. Chem. 276: 26699-26707. (Pubitemid 37412895)
4. Binz, K., P. Joller, P. Froesch, H. Binz, J. Zapf, and E. R. Froesch. 1990. Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 87: 3690-3694. (Pubitemid 20182524)
5. Kooijman, R., L. E. Scholtens, G. T. Rijkers, and B. J. M. Zegers. 1995. Differential expression of type I insulin-like growth factor receptors in different stages of human T cells. Eur. J. Immunol. 25: 931-935.
6. Landreth, K. S., R. Narayanan, and K. Dorshkind. 1992. Insulin-like growth factor-I regulates pro-B cell differentiation. Blood 80: 1207-1212.
7. Feliciello, A., A. Porcellini, I. Ciullo, G. Bonavolonta, E. V. Avvedimento, and G. Fenzi. 1993. Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 342: 337-338. (Pubitemid 23227563)
8. Agretti, P., L. Chiovato, G. De Marco, C. Marcocci, B. Mazzi, S. Sellari-Franceschini, P. Vitti, A. Pinchera, and M. Tonacchera. 2002. Realtime PCR provides evidence for thyrotropin receptor mRNA expression in orbital as well as in extraorbital tissues. Eur. J. Endocrinol. 147: 733-739. (Pubitemid 36032961)
9. Szkudlinski, M. W., V. Fremont, C. Ronin, and B. D. Weintraub. 2002. Thyroidstimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol. Rev. 82: 473-502. (Pubitemid 34654459)
10. Davies, T. F. 1996. Graves' disease. In Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text, 7th Ed. L. E. Braverman and R. D. Utiger, eds. Lippincott-Raven Publishers, Philadelphia, pp. 525-558.
11. Kazim, M., R. A. Goldberg, and T. J. Smith. 2002. Insights into the pathogenesis of thyroid associated orbitopathy: evolving rationale for therapy. Arch. Ophthalmol. 120: 380-386. (Pubitemid 34250062)
12. Paschke, R., G. Vassart, and M. Ludgate. 1995. Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathy. Clin. Endocrinol. 42: 565-569.
13. Gerding, M. N., J. W. van der Meer, M. Broenink, O. Bakker, W. M. Wiersinga, and M. F. Prummel. 2000. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin. Endocrinol. 52: 267-271. (Pubitemid 30169681)
14. Valyasevi, R. W., D. Z. Erickson, D. A. Harteneck, C. M. Dutton, A. E. Heufelder, S. C. Jyonouchi, and R. S. Bahn. 1999. Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J. Clin. Endocrinol. Metab. 84: 2557-2562.
15. Smith, T. J., and N. Hoa. 2004. Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the selfantigen, IGF-1 receptor. J. Clin. Endocrinol. Metab.. 89: 5076-5080.
16. Pritchard, J., N. Horst, W. Cruikshank, and T. J. Smith. 2002. Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. J. Immunol. 168: 942-950. (Pubitemid 34049599)
17. Pritchard, J., R. Han, N. Horst, W. W. Cruikshank, and T. J. Smith. 2003. Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the IGF-1 receptor pathway. J. Immunol. 170: 6348-6354. (Pubitemid 36682621)
18. Tramontano, D., G. W. Cushing, A. C. Moses, and S. H. Ingbar. 1986. Insulin-like growth factor-1 stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG. Endocrinology 119: 940-942. (Pubitemid 16048857)
19. Tramontano, D., A. C. Moses, R. Picone, and S. H. Ingbar. 1987. Characterization and regulations of the receptor for insulin-like growth factor-1 in the FRTL-5 rat thyroid follicular cell line. Endocrinology 120: 785-790. (Pubitemid 17020438)
20. Tramontano, D., A. C. Moses, B. M. Veneziani, and S. H. Ingbar. 1988. Adenosine 3′5′-monophosphate mediates both the mitogenic effect of thyrotropin and its ability to amplify the response to insulin-like growth factor-1 in FRTL-5 cells. Endocrinology 122: 127-132. (Pubitemid 18027592)
21. Tramontano, D., A. C. Moses, and S. H. Ingbar. 1988. The role of adenosine 3′,5′-monophosphate in the regulation of receptors for thyrotropin and insulin-like growth factor-1 in the FRTL-5 rat thyroid follicular cell. Endocrinology 122: 133-136. (Pubitemid 18027593)
22. Smith, T. J., A. Ahmed, M. G. Hogg, and P. J. Higgins. 1992. Interferon γ is an inducer of plasminogen activator inhibitor type-1 in human orbital fibroblasts. Am. J. Physiol. 263: C24-C29.
23. Smith, T. J., G. D. Sempowski, H.-S. Wang, P. J. Del Vecchio, S. D. Lippe, and R. P. Phipps. 1995. Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts. J. Clin. Endocrinol. Metab. 80: 2620-2625.
24. Gianoukakis, A. G., H. J. Cao, T. A. Jennings, and T. J. Smith. 2001. Prostaglandin endoperoxide H synthase expression in cultured human thyroid epithelial cells. Am. J. Physiol. 280: C701-C708. (Pubitemid 32466832)
25. Sinha Hikim, A. P., Y. Lue, C. M. Yamamoto, Y. Vera, S. Rodriguez, P. H. Yen, K. Soeng, C. Wang, and R. S. Swerdloff. 2003. Key apoptotic pathways for heat-induced programmed germ cell death in the testis. Endocrinology 144: 3167-3175. (Pubitemid 36819919)
26. Douglas, R. S., A. G. Gianoukakis, S. Kamat, and T. J. Smith. 2007. Aberrant expression of the IGF-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis. J. Immunol. 178: 3281-3287.
27. Haraguchi, K., H. Shimura, A. Kawaguchi, M. Ikeda, T. Endo, and T. Onaya. 1999. Effects of thyrotropin on the proliferation and differentiation of cultured rat preadipocytes. Thyroid 9: 613-619. (Pubitemid 29296125)
28. Rosenfeld, R. G., and L. A. Dollar. 1982. Characterization of the somatomedin- C/insulin-like growth factor I (SM-C/IGF-I) receptor on cultured human fibroblasts monolayers: regulation of receptor concentrations by SM-C/IGF-I and insulin. J. Clin. Endocrinol. Metab. 55: 434-440.
29. Maiorano, E., E. Perlino, V. V. Triggiani, M. Nacchiero, E. Giove, and A. Ciampolillo. 1998. Insulin-like growth factor-1 receptor in thyroid tissues of patients with Graves' disease. Int. J. Mol. Med. 2: 483-486.
30. Li. S. L., J. Kato, I. B. Paz, J. Kasuya, and Y. Fujita-Yamaguchi. 1993. Two new monoclonal antibodies against the α subunit of the human insulin-like growth factor-1 receptor. Biochem. Biophys. Res. Commun. 196: 92-98. (Pubitemid 23309479)
31. Davies, T. F., C. S. Teng, S. M. McLachlan, B. R. Smith, and R. Hall. 1978. Thyrotropin receptors in adipose tissue, retro-orbital tissue and lymphocytes. Mol. Cell. Endocrinol. 9: 303-310.
32. Wakelkamp, I. M., O. Bakker, L. Baldeschi, W. M. Wiersinga, and M. F. Prummel. 2003. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin. Endocrinol. 58: 280-287.
33. Starkey, K. J., A. Janezic, G. Jones, N. Jordan, G. Baker, and M. Ludgate. 2003. Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. J. Mol. Endocrinol. 30: 369-380.
34. Wu, S. L., C. S. Yang, H. J. Wang, C. L. Liao, T. J. Chang, and T. C. Chang. 1999. Demonstration of thyrotropin receptor mRNA in orbital fat and eye muscle tissues from patients with Graves' ophthalmopathy by in situ hybridization. J. Endocrinol. Invest. 22: 289-295.
35. Agretti, P., G. De Marco, M. De Servi, C. Marcocci, P. Vitti, A. Pinchera, and M. Tonacchera. 2005. Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation. Eur. J. Endocrinol. 152: 777-784. (Pubitemid 40744547)
36. Crisp, M., K. J. Starkey, C. Lane, J. Ham, and M. Ludgate. 2000. Adipogenesis in thyroid eye disease. Invest. Ophthalmol. Vis. Sci. 41: 3249-3255.
37. Crisp, M. S., C. Lane, M. Halliwell, D. Wynford-Thomas, and M. Ludgate. 1997. Thyrotropin receptor transcripts in human adipose tissue. J. Clin. Endocrinol. Metab. 82: 2003-2005. (Pubitemid 127495225)
38. Bell, A., A. Gagnon, L. Grunder, S. J. Parikh, T. J. Smith, and A. Sorisky. 2000. Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts. Am. J. Physiol. 279: C335-C340. (Pubitemid 30679571)
39. Endo, T., M. Ohno, S. Kotani, K. Gunji, and T. Onaya. 1993. Thyrotropin receptor in non-thyroid tissues. Biochem. Biophys. Res. Commun. 190: 774-779.
40. Endo, T., K. Ohta, K. Haraguchi, and T. Onaya. 1995. Cloning and functional expression of a thyrotropin receptor cDNA from rat fat cells. J. Biol. Chem. 270: 10833-10837.
41. + T lymphocytes in rheumatoid arthritis. Eur. J. Immunol. 28: 2661-2671.
42. Robinson, E., E. C. Keystone, T. J. Schall, N. Gillett, and E. N. Fish. 1995. Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1β production by synovial T cells. Clin. Exp. Immunol. 101: 398-407.
43. Luttrell, L. M., T. van Biesen, B. E. Hawes, W. J. Koch, K. Touhara, and R. J. Lefkowitz. 1995. Gβγ subunits mediate mitogen-activated protein kinase activation by the tyrosine kinase insulin-like growth factor 1 receptor. J. Biol. Chem. 270: 16495-16498.
44. El-Shewy, H. M., K. R. Johnson, M. H. Lee, A. A. Jaffa, L. M. Obeid, and L. M. Luttrell. 2006. Insulin-like growth factors mediate heterotrimeric G protein- dependent ERK1/2 activation by transactivating sphingosine 1-phosphate receptors. J. Biol. Chem. 281: 31399-31407.
45. Clement, S., S. Refetoff, B. Robaye, J. E. Dumont, and S. Schurmans. 2001. Low TSH requirement and goiter in transgenic mice overexpressing IGF-1 and IGF-1 receptor in the thyroid gland. Endocrinology 142: 5131-5139. (Pubitemid 33131939)
46. Park, Y. J., T. Y. Kim, S. H. Lee, H. Kim, S. W. Kim, M. Shong, Y. K. Yoon, B. Y. Cho, and D. J. Park. 2005. p66Shc expression in proliferating thyroid cells is regulated by thyrotropin receptor signaling. Endocrinology 146: 2473-2480.
47. Park, E. S., H. Kim, J. M. Suh, S. J. Park, S. H. You, H. K. Chung, K. W. Lee, O. Y. Kwon, B. Y. Cho, Y. K. Kim, et al. 2000. Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway. Mol. Endocrinol. 14: 662-670.
48. Park, E. S., H. Kim, J. M. Suh, S. J. Park, O. Y. Kwon, Y. K. Kim, H. K. Ro, B. Y. Cho, J. Chung, and M. Shong. 2000. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells. Mol. Endocrinol. 14: 440-448.
49. Cass, L. A., and J. L. Meinkoth. 1998. Differential effects of cyclic adenosine 3′,5′-monophosphate on p70 ribosomal S6 kinase. Endocrinology 139: 1991-1998. (Pubitemid 28513861)
50. Suh, J. M., J. H. Song, D. W. Kim, H. Kim, H. K. Chung, J. H. Hwang, J. M. Kim, E. S. Hwang, J. Chung, J.-H. Han, et al. 2003. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland. J. Biol. Chem. 278: 21960-21971.
51. Saunier, B., C. Tournier, C. Jacquemin, and M. Pierre. 1995. Stimulation of mitogen-activated protein kinase by thyrotropin in primary cultured human thyroid follicles. J. Biol. Chem. 270: 3693-3697.
52. Vandeput, F., S. Perpete, K. Coulonval, F. Lamy, and J. E. Dumont. 2003. Role of the different mitogen-activated protein kinase subfamilies in the stimulation of dog and human thyroid epithelial cell proliferation by cyclic adenosine 5′-monophosphate and growth factors. Endocrinology 144: 1341-1349. (Pubitemid 36428476)
53. Vecchione, A., A. Marchese, P. Henry, D. Rotin, and A. Morrione. 2003. The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like-growth factor I receptor. Mol. Cell. Biol. 23: 3363-3372. (Pubitemid 36459247)
54. Chen, C.-W., and D. Roy. 1996. Up-regulation of nuclear IGF-I receptor by short term exposure of stilbene estrogen, diethylstilbestrol. Mol. Cell. Endocrinol. 118: 1-8.
55. Lin, S.-Y., K. Makino, W. Xia, A. Martin, Y. Wen, K. Yin Kwong, L. Bourguignon, and M. C. Hung. 2001. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat. Cell Biol. 3: 802-808.
56. Baratti-Elbaz, C., N. Ghinea, O. Lahuna, H. Loosfelt, C. Pichon, and E. Milgrom. 1999. Internalization and recycling pathways of the thyrotropin receptor. Mol. Endocrinol. 13: 1751-1765. (Pubitemid 30648837)
57. Feracci, H., A. Bernadac, S. Hovsepian, G. Fayet, and S. Maroux. 1981. Aminopeptidase N is a marker for the apical pole of porcine thyroid epithelial cells in vivo and in culture. Cell Tissue Res. 221: 137-146. (Pubitemid 12167692)
58. Mauchamp, J., M. Chambard, B. Verrier, J. Gabrion, O. Chabaud, C. Gerard, C. Penel, B. Pialat, and F. Anfosso. 1987. Epithelial cell polarization in culture: orientation of cell polarity and expression of specific functions, studied with cultured thyroid cells. J. Cell Sci. (Suppl. 8): 345-358. (Pubitemid 18041169)
59. Fayet, G., and S. Hovsepian. 1980. In vitro conversion of porcine thyroid cells growing in monolayer into functional follicular cells. Biochimie 62: 27-32. (Pubitemid 10076200)
60. Beau, I., M.-T. Groyer-Picard, A. Desroches, E. Condamine, J. Leprince, J.-P. Tome, P. Dessen, H. Vaudry, and M. Misrahi. 2004. The basolateral sorting signals of the thyrotropin and luteinizing hormone receptors: an unusual family of signals sharing an unusual distal intracellular localization, but unrelated in their structures. Mol. Endocrinol. 18: 733-746. (Pubitemid 38328216)
61. Beau, I., M. Misrahi, B. Gross, B. Vannier, H. Loosfelt, M. T. Vu Hai, C. Pichon, and E. Milgrom. 1997. Basolateral localization and transcytosis of gonadotropin and thyrotropin receptors expressed in Madin-Darby canine kidney cells. J. Biol. Chem. 272: 5241-5248. (Pubitemid 27090085)
62. Halmos, G., and A. V. Schally. 2002. Changes in subcellular distribution of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) after treatment with the LH-RH antagonist cetrorelix. Proc. Natl. Acad. Sci. USA 99: 961-965. (Pubitemid 34106618)
63. 2 receptors. J. Biol. Chem. 279: 7901-7908.
64. Gianoukakis, A. G., R. S. Douglas, C. S. King, W. W. Cruikshank, and T. J. Smith. 2006. IgG from patients with Graves' disease induces IL-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T cell infiltration of the thyroid in autoimmune disease. Endocrinology 147: 1941-1949.
65. Doyle, H. A., and M. J. Mamula. 2005. Posttranslational modifications of self-antigens. Ann. NY Acad. Sci. 1050: 1-9.
66. Kent, S. C., Y. Chen, L. Bregoli, S. M. Clemmings, N. S. Kenyon, C. Ricordi, B. J. Hering, and D. A. Hafler. 2005. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 435: 224-228.
67. Nakayama, M., N. Abiru, H. Moriyama, N. Babaya, E. Liu, D. Miao, L. Yu, D. R. Wegmann, J. C. Hutton, J. F. Elliott, and G. S. Eisenbarth. 2005. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435: 220-223. (Pubitemid 40685949)
68. Bonifacio, E., M. Scirpoli, K. Kredel, M. Fuchtenbusch, and A. G. Ziegler. 1999. Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation. J. Immunol. 163: 525-532. (Pubitemid 29295882)
69. Yu, L., M. Rewers, R. Gianani, E. Kawasaki, Y. Zhang, C. Verge, P. Chase, G. Klingensmith, H. Erlich, J. Norris, and G. S. Eisenbarth. 1996. Antiislet autoantibodies usually develop sequentially rather than simultaneously. J. Clin. Endocrinol. Metab. 81: 4264-4267. (Pubitemid 26412027)
70. Skyler, J. S., J. P. Krischer, J. Wolfsdorf, C. Cowie, J. P. Palmer, C. Greenbaum, D. Cuthbertson, L. E. Rafkin-Mervis, H. P. Chase, and E. Leschek. 2005. Effects of oral insulin in relatives of patients with type 1 diabetes: the diabetes prevention trial: type 1. Diabetes Care 28: 1068-1076. (Pubitemid 40616615)